Results 211 to 220 of about 19,899 (238)

The Cell Biology of LRRK2 in Parkinson's Disease

Molecular and Cellular Biology, 2021
Annie Hiniker, Farbod Shavarebi
exaly  

LRRK2

2016
Darcie A. Cook, Malú G. Tansey
openaire   +1 more source

Inhibitors of LRRK2 kinase

2022
BEARSS DAVID JAMES, KAUWE III JOHN SAI KEONG, MOLLARD ALEXIS HENRI ABEL   +2 more
openaire   +5 more sources

[P3–070]: NOVEL ASSAYS FOR LRRK2 AND PS935 LRRK2

Alzheimer's & Dementia, 2017
Robert M. Umek, Amit Adhikari, Jill Dunty, Priya Ranganathan, Matthew Bess, Eugene Perelshteyn, Jacob N. Wohlstadter   +6 more
openaire   +1 more source

Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition

Journal of Neurochemistry, 2012
R Jeremy Nichols
exaly  

Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers

Brain, 2018
Ye Zhao, Deborah Mash, Janice Holton
exaly  

LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function

Human Molecular Genetics, 2019
Richard Wade-Martins, Natalie Connor-Robson, Rebecca Wallings   +2 more
exaly  

The R1441C mutation of LRRK2 disrupts GTP hydrolysis

Biochemical and Biophysical Research Communications, 2007
Alexandra Beylina, Mark Cookson, Elisa Greggio   +2 more
exaly  

LRRK2 in Infection: Friend or Foe?

ACS Infectious Diseases, 2019
Susanne Herbst, Maximiliano Gutierrez
exaly  

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy

Acta Neuropathologica, 2013
Dennis W Dickson, Jada Lewis, Matthew Farrer   +2 more
exaly